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Accepted 18 January 2012AbstractObjective: The aim of this study was to evaluate the value of intrauterine insemination (IUI) combined with ovarian stimulation in women with
unilateral tubal occlusion detected on hysterosalpingography (HSG).
Materials and Methods: A total of 703 patients undergoing IUI and controlled ovarian hyperstimulation were enrolled in this study. The study
group consisted of 133 patients treated for unilateral tubal occlusion diagnosed by HSG during 2005e2011. The control group consisted of 570
patients with unexplained infertility treated during the same period. In all cases of the retrospective study, menstrual cycles were regular, basal
serum follicle-stimulating hormone levels and sperm parameters were normal.
Results: There were no significant differences in pregnancy rate per cycle between the study (17.3%) and control groups (18.9%). The pregnancy
rate was higher in patients with proximal tubal occlusion (21.7%) compared with mid-distal tubal occlusion (12.5%) or unexplained infertility
(18.9%), but the difference was not statistically significant.
Conclusions: Infertile patients with only unilateral proximal tubal occlusion detected on HSG can be treated initially by IUI combined with
ovarian stimulation. The cycle outcomes in patients with proximal tubal occlusion are similar to patients with unexplained infertility. However,
the stimulated IUI might not be a good choice for patients with unilateral mid-distal tubal occlusion because of a lower success rate, although
further evidence is needed.
Copyright  2013, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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Tubal dysfunction with or without associated peritoneal
pathology accounts for up to 35% of all infertility and repre-
sents more than 50% of the etiologies of female infertility
[1e3]. It has become one of the most common causes of
infertility and its incidence is increasing, primarily due to
rising rates of sexually transmitted infection and resultant
pelvic inflammatory disease. Risk factors for tubal disease
including prior pelvic infection, intrauterine device usage,* Corresponding author.
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http://dx.doi.org/10.1016/j.tjog.2012.01.037previous ectopic pregnancy, septic abortion, appendiceal dis-
ease, or diethylstilbestrol exposure should all prompt the
physician to move quickly toward assessment of tubal
function.
Hysterosalpingography (HSG) and laparoscopy are two
common methods used to assess the status of both tubal pa-
tencies. The HSG images display the contour of uterine cavity
and the internal architecture of the tubal lumen that cannot be
evaluated by laparoscopy. Furthermore, HSG is inexpensive
and less invasive than laparoscopy and generally should be
performed prior to the operative procedure. In addition, some
investigators suggest using Chlamydia antibody as a screen
test for tubal infertility [4,5].cs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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patent tubes or with bilateral obstructed tubes detected on
HSG is clear and direct. However, no standard management is
offered to patients with unilateral occlusion. There are four
possible approaches for patients with unilateral tubal occlu-
sion: (1) repeat HSG; (2) further evaluation and correction of
tubal and pelvic lesions via laparoscopy or catheterization; (3)
attempting to achieve pregnancy with controlled ovarian hy-
perstimulation (COH) and intrauterine insemination (IUI)
through one patent tube; and (4) referring for in-vitro fertil-
ization (IVF) to bypass the problem.
The information available to date on the results after
COH and IUI in patients with unilateral tubal occlusion
diagnosed by HSG is sparse. The purpose of the present
study was to investigate the role of stimulated IUI in these
patients.
Materials and methodsPatient selectionThe study group consisted of the patients who received
stimulated IUI at Mackay Memorial Hospital during
2005e2011 and met the following criteria: (1) age <40
years; (2) only unilateral tubal occlusion diagnosed by HSG;
(3) regular menstrual cycles with normal basal serum follicle
stimulating hormone (FSH), luteinizing hormone (LH),
prolactin, and thyroid stimulating hormone; and (4) normal
sperm parameters. The control group consisted of patients
with unexplained infertility treated during the same period
and met the same inclusion criteria, except for normal
findings on HSG. All women of both groups were treated by
one of three senior physicians with the same COH and IUI
procedures. Data were collected retrospectively by chart
review for selected patients. The Institutional Review Board
of our hospital approved the use of patients’ medical
records.Ovarian stimulationTable 1
Comparison of basic clinical parameters between the two groups.
Clinical parameters Unilateral tubal
occlusion
(n ¼ 133)
Unexplained
infertility
(n ¼ 570)
p
Age (y) 33.4  4.2 32.9  3.6 NS
BMI (kg/m2) 22.1  4.3 21.7  3.5 NS
Serum AMH (ng/mL) 3.0  4.5 3.2  5.2 NS
Previous abdominal surgery 38 (28.6) 28 (4.9) <0.001
Semen volume (mL) 3.2  1.5 3.3  1.7 NS
Sperm concentration
(109/L)
68.0  46.0 77.8  51.4 NS
Sperm motility (%) 59.2  15.4 60.8  18.1 NS
Data are presented as mean  standard deviation or n (%).
AMH ¼ anti-Mu¨llerian hormone; BMI ¼ body mass index; NS ¼ not
significant.All IUI cycles were initiated on the Day 3 of menstrual
cycle and were continued until ovulation. Ovarian stimulation
was performed using recombinant FSH (Gonal F; Merck
Serono, Geneva, Switzerland or Puregon; Oragnon Interna-
tional Inc., Roseland, NJ, USA), or human menopausal
gonadotropin (Menopur; Ferring SAS, St Prex, Switzerland).
The starting dose of gonadotropin was 75e150 IU according
to the status of the patient. Follicular development was
monitored by vaginal ultrasound and serum estradiol levels,
and the dose of FSH or human menopausal gonadotropin was
adjusted accordingly every 1e3 days. Ovulation was induced
with 10,000 IU human chorionic gonadotropin (hCG, Profast;
Merck Serono) when at least one follicle had a diameter of
18 mm. A single IUI was performed 36 hours after admin-
istration of hCG. If an LH surge was assumed by positive urine
LH test on the triggering day, IUI was performed the day after
hCG trigger.IUI and luteal supportSemen was collected 2 hours prior to the insemination and
after 48e72 hours of abstinence. Density gradient method
(Sperm gradient kits; Cook Medical, Brisbane, Australia) was
used for sperm preparation. A 2-week course of daily treat-
ment with micronized progesterone (Utrogestan; Cassenne-
Aventis, Paris, France) vaginally was prescribed for luteal
phase support.
Pregnancy was initially detected 16e20 days after admin-
istration of hCG. Ultrasound was performed at 6 weeks of
gestation to confirm fetal viability. The presence of a gesta-
tional sac detected by ultrasound was defined as clinical
pregnancy. Women with clinical pregnancy who miscarried
prior to the Week 12 were defined as spontaneous abortion.Statistical analysisResults are presented as mean values  standard deviation.
The SPSS version 17.0 (SPSS, Inc., Chicago, IL, USA) was
used for data management and analysis. Categorical variables
were compared using a Chi-squared test, and continuous var-
iables were analyzed using Student t test. A p value <0.05 was
considered statistically significant.
Results
The initial sample consisted of 185 women with unilateral
tubal occlusion and 588 women with unexplained infertility. In
the unilateral tubal occlusion group, six patients whose age
was 40 years underwent stimulated IUI twice and 46 patients
had combined male and female causes. These 52 patients were
excluded from this study. Among the unexplained infertility
group, 18 patients who underwent stimulated IUI twice were
also excluded due to old age (40 years). Finally, we studied a
total of 703 IUI cycles in 703 patients including unilateral
tubal occlusion group (n ¼ 133) and unexplained infertility
group (n ¼ 570).
No between-group differences in mean age, BMI, serum
AMH, or sperm parameters were found (Table 1). However,
previous abdominal surgery was significantly higher in
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plained infertility (28.6% vs. 4.9%, respectively; p < 0.001).
There were no significant differences in days of ovarian
stimulation, total dose of gonadotropin injection, and number
of follicle (16 mm) between the study and control groups
(Table 2). The pregnancy rates after COH and IUI were 17.3%
(23/133) in the study group, and 18.9% (108/570) in the
control group ( p > 0.05). The pregnancy rate per cycle was
lower in the patients with mid-distal occlusion than those with
proximal occlusion, but was not statistically significant (12.5%
vs. 21.7%, respectively; p > 0.05). Similarly, the patients with
mid-distal occlusion had lower pregnancy rates than those with
unexplained infertility (12.5% vs 18.9%, respectively;
p > 0.05). There were no complications with pelvic inflam-
matory disease in either group.
Discussion
The HSG is valuable as a nonsurgical initial test for tubal
patency. Although laparoscopy is important for diagnosing
pelvic adhesions and endometriosis, a normal HSG result is
followed by conception within 6 months in 30e50% of cases
[6]. Diagnostic laparoscopy can be delayed or omitted if HSG
findings are normal. If the HSG reveals bilateral tubal
obstruction, however, either laparoscopy to confirm the diag-
nosis or IVF to skip the problem should be indicated. How-
ever, management of the patients with unilateral tubal
occlusion diagnosed by HSG remains without consensus of
opinion. Several possible approaches including repeat HSG,
operative hystero-falloposcopy, ultrasound-guided tubal cath-
eterization, selective salpingography, laparoscopy, stimulated
IUI, and IVF have been recommended.
A retrospective cohort study of 359 patients that evaluated
the prognostic significance of HSG for fertility outcome found
that the adjusted pregnancy rates were 0.81 (95% confidence
interval, 0.47e1.4) for a one-sided tubal pathology, but only
0.30 (95% confidence interval, 0.13e0.71) for a two-sided
pathology [7]. The authors concluded that unilateral tubal
pathology detected on HSG has virtually similar fertility
prospects to normal HSG and limited prognostic significanceTable 2
Comparison of IUI cycle outcomes between the two groups.
Clinical outcomes Unilateral
tubal occlusion
(n ¼ 133)
Unexplained
infertility
(n ¼ 570)
p
Days of ovarian stimulation 10.1  2.4 9.8  2.3 NS
Total dose of gonadotropins (IU) 535  252 528  234 NS
Number of follicles (16 mm) 2.7  1.6 2.8  1.4 NS
Clinical pregnancy rate (%) 17.3 (23/133) 18.9 (108/570) NS
Pregnancy rate of proximal
tubal occlusion (%)
21.7 (15/69)a
Pregnancy rate of mid-distal
tubal occlusion (%)
12.5 (8/64)b
Data are presented as mean  standard deviation.
NS ¼ not significant.
a p > 0.05 compared with the unexplained group; b p > 0.05 compared
with the proximal tubal occlusion and unexplained groups.for fertility, whereas bilateral tubal pathology detected on
HSG obviously reduced fertility prospects. Therefore, they
suggested that the therapeutic strategy of patients with an HSG
finding of unilateral tubal pathology should not differ from the
therapeutic strategy in patients with a normal HSG, because
these groups of patients have similar fertility prospects. By
contrast, laparoscopy should be considered in patients with an
HSG finding of bilateral tubal pathology, because one third of
these patients may alter the original treatment plan from IVF
to COH with IUI [8].
In our study, the pregnancy rates of single stimulated IUI in
patients with unilateral tubal occlusion were similar to those
with unexplained infertility. Furthermore, the subgroup of
these women with proximal occlusion of a single tube has
better pregnancy rates than those with unilateral mid-distal
occlusion. Our results are in agreement with those of Farhi
[9], which demonstrated that the cumulative pregnancy rate
with three cycles of stimulated IUI was not significantly
different between the unilateral tubal occlusion group (30.9%)
and unexplained infertility group (42.6%), and was lower in
mid-distal tubal occlusion (19%) than in proximal tubal oc-
clusion (38.2%). A previous study also reported that the
pregnancy rate after single stimulated IUI was similar in cases
of unilateral proximal occlusion and unexplained infertility,
but lower in cases of unilateral distal occlusion [10]. However,
it was a small retrospective study and multiple types of ovarian
stimulation were grouped together.
Proximal tubal occlusion detected on HSG may be a false-
positive result that the tube is truly patent on subsequent
testing. Several situations such as tubal spasm, temporary
plugs of debris or amorphous material [11], and underfilling of
the tube may cause a false finding of proximal occlusion. A
false-positive rate as high as 15% for proximal tubal occlusion
on HSG has been noted in the literature [12]. Indeed, a pro-
spective study demonstrated that a repeat HSG achieved
bilateral patency in 24 of 40 patients (60%) who were diag-
nosed with proximal tubal occlusion on initial HSG [13]. The
second HSG can only improve the diagnosis of tubal patency,
but unlike stimulated IUI that can treat the infertile patient
with unilateral tubal occlusion as unexplained infertility with
bilateral tubal patency. In our study, a higher pregnancy rate
found in the unilateral proximal occlusion group may reflect
the false positive reading of proximal occlusion on HSG.
Laparoscopy is currently regarded as the most reliable tool
in the diagnosis of tubal infertility. For clinical practice,
laparoscopy can be delayed until tubal pathology is found on
initial HSG. In patients with a normal HSG, laparoscopy is
only performed in cases where infertility has persisted for a
longer period time [14]. A meta-analysis study on the sur-
gical treatment of proximal tubal disease showed that
microsurgical anastomosis can achieve a near 50% pregnancy
rate. Pregnancy rates in a selected series of transcervical
tubal cannulation were similar to those reported in micro-
surgery. In addition, the authors suggested that macrosurgery
was indicated only in cases of complete obliteration of the
intramural fallopian tube because macrosurgery had a lower
success rate than microsurgery [15].
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reported that there was no significant difference in pregnancy
rates of patients with mild tubal disease between laparoscopy
and conventional laparotomy group. However, the pregnancy
rate of patients with severe tubal disease was significantly
higher in the laparotomy group. Appropriate patient selection
is the main factor affecting outcome in terms of fertility [16].
In a prospective study comparing results of laparotomy plus
microsurgery and laparoscopy for the treatment of distal tubal
occlusion, both methods were equally effective in restoring
fertility in women with comparable tubal damage. As stated
above, the severity of the tubal damage is a critical factor for
the surgical outcomes [17].
In the pre-IVF era, surgical intervention of tubal disease
was the only available treatment for tubal infertility. There-
after, IVF has gradually replaced tubal surgery as the treat-
ment of choice for tubal infertility and become the treatment
of last resort for persistent infertility due to any cause. In
contrast to tubal surgery, IVF cannot correct the tubal abnor-
malities, but can bypass the tubal problem and create a clinical
pregnancy directly for patients with only tubal or combined
with other associated infertility factors. Benadiva et al [18]
demonstrated the Cornell experience that cumulative preg-
nancy rates in women with tubal infertility were >70% after
four cycles of treatment with IVF, and were significantly
higher than those after surgical correction, especially in older
women. Other studies have also revealed that the cost effec-
tiveness of reconstructive surgery in unselective patients with
distal tubal occlusion is apparently lower than for IVF [19,20].
These findings indicate that laparoscopic surgery may be
viewed as an alternative to IVF in younger women with mild
distal tubal disease, but IVF will be the logical choice if the
disease becomes severe or pregnancy is not achieved during
the first postoperative year. In older women with any signifi-
cant degree of tubal disease, IVF should be offered first
because the fertility potential declines rapidly with advancing
age and IVF is more efficient than tubal surgery. Unfortu-
nately, to date, there are no studies designed to compare
pregnancy rates or time to conception between stimulated IUI
and surgical treatment in patients with unilateral tubal
occlusion.
IUI is often suggested to infertile couples in which the
woman has at least one permeable fallopian tube and the man
has mild to moderate male factor infertility. IUI combined
with COH offers a number of advantages. It increases the
number of oocytes that have the potential for fertilization. It
raises the woman’s hormone level, eliminates seminal plasma,
and markedly increases the number of sperm reaching the
uterine cavity. There are many protocols of ovulation induc-
tion provided for COH and IUI. Chung et al [21] suggested
that combining low-dose recombinant FSH and clomiphene
citrate might be an ideal treatment for IUI. However, the
outcomes observed in a large case series strongly suggested
that exogenous gonadotropin stimulation increases cycle
fecundability in therapeutic donor insemination cycles, and
cycle fecundability is more than twice that observed in
clomiphene-stimulated cycles [22]. Meanwhile, the cyclefecundability observed in spontaneous and clomiphene-
stimulated therapeutic donor insemination cycles is similar,
suggesting that clomiphene stimulation has little or no added
value [23]. Thus, in this study, we used recombinant FSH
without clomiphene for ovarian stimulation to avoid the
adverse antiestrogen effects of clomiphene on endometrium.
To the best of our knowledge, this study includes the largest
case number to report the pregnancy rate in women with uni-
lateral tubal occlusion detected on HSGwhowere treated with a
single stimulated IUI. In conclusion, our observations suggest
that stimulated IUI can be offered as the first line option in
women with unilateral proximal tubal occlusion. For women
with mid-distal tubal occlusion, stimulated IUI might not be a
good choice because of a lower success rate, and either surgical
intervention or IVF might be preferred, although further evi-
dence is needed. Further large-scale prospective randomized
studies are needed to establish an appropriate management
protocol of unilateral tubal factor infertility.
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